Contracts: DHS orders LaserCard next generation Green Card encoding solution

Iomai Corp., of Gaithersburg, MD, announced it will receive a cost-reimbursement grant for up to $943,856 from the U.S. Army Medical Research and Materiel Command (USAMRMC) to perform pre-clinical work on a patch-based version of the anthrax vaccine. Under the one-year grant, Iomai scientists will use vaccine antigen developed by UK-based Avecia Biologics Ltd., applying Iomai's technology in an effort to formulate a dry version of the antigen that can be combined with an Iomai adjuvant on a needle-free patch. Iomai will then evaluate the stability of the patch to determine whether it can be stored and shipped at room temperature.
- Add your comment
- trackback url: http://www.gsnmagazine.com/cms/trackback/670-3
